三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02197 三叶草生物-B

未开盘 07-23 16:08:06

1.660

+0.050

+3.11%

最高1.700	最低1.610	成交量322.45万
今开1.610	昨收1.610	日振幅5.59%
总市值21.55亿	流通市值21.55亿	总股本12.98亿
成交额535.81万	换手率0.25%	流通股本12.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02197","market":"HK","secType":"STK","nameCN":"三叶草生物-B","latestPrice":1.66,"timestamp":1784794086003,"preClose":1.61,"halted":0,"volume":3224500,"delay":0,"changeRate":0.0310559006211179,"floatShares":1298000000,"shares":1298000000,"eps":-0.162724,"marketStatus":"未开盘","change":0.05,"latestTime":"07-23 16:08:06","open":1.61,"high":1.7,"low":1.61,"amount":5358100,"amplitude":0.055901,"askPrice":1.66,"askSize":14500,"bidPrice":1.64,"bidSize":18500,"shortable":3,"etf":0,"ttmEps":-0.181081,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":0,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":1.61,"openAndCloseTimeList":[[1784770200000,1784779200000],[1784782800000,1784793600000]],"volumeRatio":0.48403367379334367,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02197","defaultTab":"news","newsList":[{"id":"2652211269","title":"港股异动 | 三叶草生物-B(02197.HK)涨超5% 预计上半年扭亏为盈赚最多12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652211269?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:03","pubTimestamp":1784516588,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268610","title":"三叶草生物-B在港交所公告，本集团截至2026年6月30日止六个月预期将录得净利润约人民币9.57亿元至12.04亿元，","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268610","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652268610?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:16","pubTimestamp":1784503010,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426857","title":"三叶草生物-B(02197)发盈喜 预期中期净利润约9.57亿元至12.04亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426857","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652426857?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:06","pubTimestamp":1784502397,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，本集团截至2026年6月30日止六个月预期将录得净利润约人民币9.57亿元至12.04亿元，而去年同期则录得净亏损约人民币 1.013 亿元。撇除该收益的会计影响，本集团截至2026年6月30日止六个月预期将继续录得净亏损，主要反映本集团持续投入研发活动及缺乏重大经营收入所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"三叶草生物-B(02197)发盈喜 预期中期净利润约9.57亿元至12.04亿元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143562010","title":"三叶草生物-B（02197）发布正面盈利预告：2026年上半年预盈9.57亿至12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143562010","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143562010?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:05","pubTimestamp":1784502334,"startTime":"0","endTime":"0","summary":"2026年7月20日，三叶草生物-B公告称，基于对集团截至2026年6月30日止六个月未经审计合并管理账目的初步审阅，公司预计期内将实现净利润约人民币9.57亿元至12.04亿元，而上一同期录得净亏损约人民币1.013亿元。公司指出，业绩由亏转盈主要源于全资附属公司三叶草生物制药（香港）有限公司与Gavi于2026年3月22日签订的和解协议所产生的会计收益，金额约人民币10.89亿元至13.36亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183436479","title":"三叶草生物-B预计2026年上半年净利润达9.57亿至12.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183436479","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183436479?lang=zh_cn&edition=full","pubTime":"2026-07-20 07:05","pubTimestamp":1784502319,"startTime":"0","endTime":"0","summary":"三叶草生物-B（股票代码：02197）发布业绩预告，预计截至2026年6月30日的六个月期间，公司净利润将介于人民币9.57亿元至12.04亿元之间。这一预测数据反映了公司在该期间内的整体财务表现预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127840401","title":"三叶草生物-B6月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1127840401","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127840401?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:13","pubTimestamp":1783069986,"startTime":"0","endTime":"0","summary":"三葉草生物製藥有限公司于2026年7月3日发布截至2026年6月30日的股份变动月报表。报告显示，公司在报告期内各项股本数据保持稳定，未发生新增发行、回购或注销活动。报告期末已发行的普通股数量为1,298,413,056股，亦无增减变化，库藏股期末数目为零。三葉草生物製藥有限公司确认已遵守香港联合交易所有限公司《上市规则》及相关法律和监管规定。此次月报由公司董事梁朋签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186053321","title":"三叶草生物-B公布5月股份变动月报 新增发行179,252股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186053321","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186053321?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:37","pubTimestamp":1780475825,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年6月3日披露截至2026年5月31日的股份变动月报表。公告显示，本期法定/注册股本及面值均未发生变化，至2026年5月底，公司注册股本仍为2,000,000,000股普通股、每股面值USD 0.0001，对应总额USD 200,000。报告期内，普通股由上月底的1,298,233,804股增至1,298,413,056股，增加179,252股，库藏股数目保持为0。截至2026年5月31日，公司确认满足香港联交所关于公众持股量的相关要求。该公告由公司董事梁朋代表董事会签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149993793","title":"三叶草生物-B拟回购不超过10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1149993793","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149993793?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:06","pubTimestamp":1779786384,"startTime":"0","endTime":"0","summary":"三叶草生物-B于近日发布公告，拟在即将召开的股东周年大会上寻求股东批准一项股份购回授权，最高可回购不超过公司当前已发行股本的10%。根据公告，截至最后实际可行日期，公司已发行股本合计为1,298,380,556股，若授权获批，回购规模可达129,838,055股。公司董事会指出，适时进行购回有助于提升股东回报和优化公司资本结构，并表示回购股份的计划符合公司及全体股东的最佳利益。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三叶草生物-B拟回购不超过10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06186","06609","09626","02126","09992","02256","00169","06049","09888","02618","01548","02252","01833","02171","00719","06060","01783","81024","02172","01905","01951","03692","09688","06963","09858","09699","00909","02192","03700","02285","06660","00136","01440","02276","02306","01952","06969","02096","00772","06160","01024","06996","02197","02013","03888","00013","01357","02158","00762","01060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188980056","title":"港股部分生物医药股走强！银诺医药-B涨超42%，三叶草生物-B涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188980056","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188980056?lang=zh_cn&edition=full","pubTime":"2026-05-11 13:25","pubTimestamp":1778477154,"startTime":"0","endTime":"0","summary":"5月11日，港股部分生物医药股走强，$银诺医药-B(02591)$涨超42%，$三叶草生物-B(02197)$涨超11%，$君实生物(01877)$涨超8%，$来凯医药-B(02105)$涨超7%，$荃信生物-B(02509)$涨近5%，$药明巨诺-B(02126)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","399441","BK4581","02197","BK4588","XBI","BK1161","VXUS","161726","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192990862","title":"三叶草生物-B4月股份变动月报表：新增发行195,377股","url":"https://stock-news.laohu8.com/highlight/detail?id=1192990862","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192990862?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:53","pubTimestamp":1778057592,"startTime":"0","endTime":"0","summary":"三叶草生物制药有限公司于2026年5月6日发布截至2026年4月30日的证券变动月报表。报告显示，公司法定股本共2,000,000,000股，面值为每股USD 0.0001，法定股本总额USD 200,000，与上月末持平。截至4月30日，三叶草生物-B已发行股份由上月末的1,298,038,427股增加至1,298,233,804股，单月合计新增195,377股；本月末公司无库存股。本次月报由董事梁朋签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193037101","title":"三叶草生物-B（02197）2025年收入大幅下滑 亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1193037101","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193037101?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:36","pubTimestamp":1776940599,"startTime":"0","endTime":"0","summary":"三叶草生物-B在2025年度实现收入人民币3,505万元，同比2024年度的人民币3.84亿元大幅下降90.9%。主要原因来自上一年度对AdimFlu-S产品的商业销售已终止及退货调整所致。与此对应，公司年内亏损从2024年度的人民币9.03亿元收窄至人民币2.05亿元，降幅达77.3%，经调整亏损为人民币1.98亿元。总体而言，三叶草生物-B在2025年收入虽显著下滑，但核心亏损大幅缩减，表明公司在聚焦创新疫苗业务的同时，已实施降本增效措施。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"三叶草生物-B（02197）2025年收入大幅下滑 亏损显著收窄","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128168058","title":"三叶草生物-B3月股份变动月报，新增发行1,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1128168058","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128168058?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:38","pubTimestamp":1775723939,"startTime":"0","endTime":"0","summary":"三叶草生物製藥有限公司于2026年4月9日披露2026年3月股份变动月报表。本次月报显示，该公司截至2026年3月31日的注册股本维持2,000,000,000股，面值为每股USD 0.0001，总注册股本为USD 200,000。该新增发行主要来自首次公开发售前购股权计划。此外，首次公开发售后购股权计划本月无实质行使，但授出新购股权10,195,500股。公司在月报中确认，已满足适用的公众持股量要求。根据月报内容，截至3月底，公司股份结构保持相对稳定，期末已发行股本合计1,298,038,427股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626906423","title":"港股异动 | 三叶草生物-B(02197)再涨超7% 三叶草生物呼吸道联合疫苗II期临床迎新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2626906423","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626906423?lang=zh_cn&edition=full","pubTime":"2026-04-09 14:42","pubTimestamp":1775716964,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三叶草生物-B再涨超7%，截至发稿，涨5.21%，报3.03港元，成交额3064.97万港元。消息面上，三叶草生物此前公告，评估集团自研专有的呼吸道联合疫苗候选产品SCB-1022及SCB-1033的澳洲II期临床试验已完成受试者招募。初步临床结果预计于2026年第三季度公布。此外，三叶草生物近期与全球疫苗免疫联盟达成和解。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02197","BK4585","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623630863","title":"三叶草生物-B(02197)：完成呼吸道合胞病毒(RSV) + 人偏肺病毒(hMPV) + 副流感病毒3型 (PIV3) 呼吸道联合疫苗候选产品澳洲II期临床试验受试者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=2623630863","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623630863?lang=zh_cn&edition=full","pubTime":"2026-03-30 06:19","pubTimestamp":1774822765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B 发布公告，评估公司自研专有的呼吸道联合疫苗候选产品 SCB1022  及 SCB1033  的澳洲II期临床试验已完成受试者招募。叁叶草生物RSV联合疫苗候选产品进行中的II期是一项随机、观察者单盲、多中心研究的临床试验， 在澳洲招募420名老年受试者，受试者随机配接种 SCB1022、 SCB1033或安慰剂。该临床试验评估公司RSV联合候选疫苗产品的安全性、反应原性与免疫原性，预计于2026 年第三季获得初步结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821534","title":"三叶草生物-B(02197)授出1019.55万份购股权及896.5万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821534","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622821534?lang=zh_cn&edition=full","pubTime":"2026-03-27 20:38","pubTimestamp":1774615127,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B(02197)发布公告，于2026年3月27日，公司根据首次公开发售后购股权计划及受限制股份单位计划的条款分别向若干合资格参与者授出合共1019.55万份购股权及896.5万个受限制股份单位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198309307","title":"异动解读 | 三叶草生物-B盘中大涨5.32%，全年亏损大幅收窄提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1198309307","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198309307?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:59","pubTimestamp":1774490379,"startTime":"0","endTime":"0","summary":"三叶草生物-B今日盘中股价大幅上涨5.32%，引起了市场的关注。消息面上，公司发布了截至2025年12月31日止的年度业绩报告。报告显示，公司全年净亏损为2.05亿元人民币，较上年同期的9.03亿元大幅收窄77.3%；若以非国际财务报告准则计，经调整年内亏损为1.98亿元，上年同期为8.87亿元。尽管公司收入同比大幅下滑，但亏损状况的显著改善，被市场视为积极的财务信号，这可能是推动股价在交易时段内走强的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182919544","title":"异动解读 | 年度业绩显示收入暴跌90.9%，三叶草生物-B盘中大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182919544","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182919544?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:34","pubTimestamp":1774488854,"startTime":"0","endTime":"0","summary":"三叶草生物-B今日盘中股价大跌5.32%，市场表现受到其最新发布的财务数据显著影响。消息面上，公司于盘前发布了截至2025年12月31日止年度的业绩报告。报告显示，公司年度收入仅为人民币350.5万元，同比大幅下滑90.9%。此外，公司现金及银行结余也从上一年度的约5.57亿元减少至约2.71亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622589883","title":"三叶草生物-B(02197)发布年度业绩 净亏损2.05亿元 同比收窄77.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622589883","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622589883?lang=zh_cn&edition=full","pubTime":"2026-03-26 07:13","pubTimestamp":1774480415,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三叶草生物-B(02197)发布截至2025年12月31日止年度业绩，集团收入人民币350.5万元，同比减少90.88%;研发开支1.82亿元，同比减少0.57%;净亏损2.05亿元，同比收窄77.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02197","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196681623","title":"三叶草生物-B 2025年收入下降，年内亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1196681623","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196681623?lang=zh_cn&edition=full","pubTime":"2026-03-26 06:20","pubTimestamp":1774477209,"startTime":"0","endTime":"0","summary":"三叶草生物-B于本报告期内录得收入人民币3,505千元，相比2024年度的人民币38,419千元有所下降。其他收入及收益在2025年和2024年分别为人民币54,098千元与人民币97,215千元，销售及分销开支分别达人民币5,070千元与人民币19,705千元，行政开支则为人民币66,332千元与人民币75,172千元。研发开支主要用于临床试验及相关雇员开支，两年分别为人民币182,338千元及人民币183,387千元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cloverbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0829},{"period":"1month","weight":-0.0726},{"period":"3month","weight":-0.4411},{"period":"6month","weight":-0.3083},{"period":"1year","weight":1.8621},{"period":"ytd","weight":-0.2906}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.0803},{"period":"3month","weight":-0.0295},{"period":"6month","weight":-0.0575},{"period":"1year","weight":-0.0128},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"三叶草生物制药有限公司是一家主要从事创新型疫苗的研发、生产和商业化的投资控股公司。该公司的产品及候选疫苗包括呼吸道合胞病毒（RSV）疫苗（SCB-1019）、四价季节性流感疫苗AdimFlu-S、SCB-219M、新冠疫苗等。该公司依托Trimer-Tag技术平台开展可解决未满足需求的创新疫苗的研发（R&D），专注于建立呼吸道疫苗专营权，并在儿科疫苗市场创立业务。Trimer-Tag技术平台是一个基于天然依赖三聚体化功能的靶点用于研制重组蛋白疫苗的产品开发平台。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.113925},{"month":2,"riseRate":0.4,"avgChangeRate":0.011169},{"month":3,"riseRate":0.2,"avgChangeRate":-0.104268},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028136},{"month":5,"riseRate":0.4,"avgChangeRate":-0.154826},{"month":6,"riseRate":0.4,"avgChangeRate":-0.025093},{"month":7,"riseRate":0.6,"avgChangeRate":0.127106},{"month":8,"riseRate":0.5,"avgChangeRate":0.089271},{"month":9,"riseRate":0.5,"avgChangeRate":0.326004},{"month":10,"riseRate":0,"avgChangeRate":-0.070872},{"month":11,"riseRate":0.75,"avgChangeRate":0.569272},{"month":12,"riseRate":0.2,"avgChangeRate":-0.160916}],"exchange":"SEHK","name":"三叶草生物-B","nameEN":"CLOVER BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三叶草生物-B,02197,三叶草生物-B股票,三叶草生物-B股票老虎,三叶草生物-B股票老虎国际,三叶草生物-B行情,三叶草生物-B股票行情,三叶草生物-B股价,三叶草生物-B股市,三叶草生物-B股票价格,三叶草生物-B股票交易,三叶草生物-B股票购买,三叶草生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三叶草生物-B(02197)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三叶草生物-B(02197)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}